RYVERNA
DEAD

Serial Number

86329887

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jul 7, 2014

Add to watchlist:

No watchlists yet
View on USPTO

RYVERNA Trademark

Serial Number: 86329887

RYVERNA is a trademark filed by NOVARTIS AG on July 7, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

July 7, 2014

Registration Date

Not Registered

Published for Opposition

September 23, 2014

Goods & Services

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of kidney diseases; Pharmaceutical preparations for the prevention and treatment of diabetes; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; Pharmaceutical products for the prevention and treatment of bone diseases; Pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Dec 26, 2017 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 25, 2017 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 6, 2017 EXRA
SOU EXTENSION 5 GRANTED
May 5, 2017 EX5G
SOU EXTENSION 5 FILED
May 1, 2017 EXT5
SOU TEAS EXTENSION RECEIVED
May 1, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 18, 2016 EXRA
SOU EXTENSION 4 GRANTED
Nov 17, 2016 EX4G
SOU EXTENSION 4 FILED
Nov 15, 2016 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 15, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 21, 2016 EXRA
SOU EXTENSION 3 GRANTED
Jun 18, 2016 EX3G
SOU EXTENSION 3 FILED
May 13, 2016 EXT3
SOU TEAS EXTENSION RECEIVED
May 13, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 9, 2015 EXRA
SOU EXTENSION 2 GRANTED
Dec 8, 2015 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 8, 2015 AITU
SOU EXTENSION 2 FILED
Nov 16, 2015 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 16, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 15, 2015 EXRA
SOU EXTENSION 1 GRANTED
May 13, 2015 EX1G
SOU EXTENSION 1 FILED
May 13, 2015 EXT1
SOU TEAS EXTENSION RECEIVED
May 13, 2015 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 18, 2014 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 23, 2014 NPUB
PUBLISHED FOR OPPOSITION
Sep 23, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 3, 2014 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 18, 2014 CNSA
ASSIGNED TO EXAMINER
Aug 15, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 10, 2014 NWOS
NEW APPLICATION ENTERED
Jul 10, 2014 NWAP